Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT20230210057378N1Phase 3Completed
Phase 3, randomised, double-blind trial of articaine and lidocaine in Jawbone defect, sponsored by Qazvin University of Medical Sciences. Started Mar 2023; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT20230210057378N1.